Class information for:
Level 2: HAEMOPHILIA//HAEMOPHILIA A//VON WILLEBRAND DISEASE

Basic class information

ID Publications Average number
of references
Avg. shr. active
ref. in WoS
618 13204 30.8 71%



Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 3)



ID, lev.
above
Publications Label for level above
48 92304 HAEMOPHILIA//HEMATOLOGY//THROMBOSIS AND HAEMOSTASIS

Classes in level below (level 1)



ID, lev. below Publications Label for level below
601 3175 VON WILLEBRAND DISEASE//VON WILLEBRAND FACTOR//VWD
1130 2737 FACTOR VIII//FACTOR VIII INHIBITOR//ACQUIRED HEMOPHILIA
1660 2469 HAEMOPHILIA//VAN CREVELDKLIN//HEMOPHILIA
6718 1377 RFVIIA//RECOMBINANT ACTIVATED FACTOR VII//RECOMBINANT FACTOR VIIA
7118 1327 ASSAY DISCREPANCIES//HEMOPHILIA TREATMENT//FACTOR VIII CONCENTRATE
8267 1201 FACTOR VIII GENE//F8 GENE//INTRON 22 INVERSION
18413 487 ACQUIRED VON WILLEBRAND SYNDROME//ACQUIRED VON WILLEBRAND DISEASE//ACQUIRED VON WILLEBRANDS SYNDROME
19631 431 DESMOPRESSIN//DDAVP//PHARMACOLOGY DESMOPRESSIN

Terms with highest relevance score



Rank Term Type of term Relevance score
(tfidf)
Class's shr.
of term's tot.
occurrences
Shr. of publ.
in class containing
term
Num. of publ.
in class
1 HAEMOPHILIA Journal 3122 76% 16% 2160
2 HAEMOPHILIA A Author keyword 1156 88% 4% 555
3 VON WILLEBRAND DISEASE Author keyword 1087 82% 5% 641
4 FACTOR VIII Author keyword 979 65% 7% 935
5 HEMOPHILIA A Author keyword 628 75% 3% 454
6 HEMOPHILIA Author keyword 466 52% 5% 630
7 HAEMOPHILIA B Author keyword 378 87% 1% 188
8 VON WILLEBRAND FACTOR Author keyword 330 35% 6% 769
9 RFVIIA Author keyword 327 82% 1% 191
10 FACTOR VIII INHIBITORS Author keyword 305 96% 1% 95

Web of Science journal categories

Author Key Words



Rank Web of Science journal category Relevance score
(tfidf)
Class's shr.
of term's tot.
occurrences
Shr. of publ.
in class containing
term
Num. of publ.
in class
LCSH search Wikipedia search
1 HAEMOPHILIA 1740 74% 10% 1299 Search HAEMOPHILIA Search HAEMOPHILIA
2 HAEMOPHILIA A 1156 88% 4% 555 Search HAEMOPHILIA+A Search HAEMOPHILIA+A
3 VON WILLEBRAND DISEASE 1087 82% 5% 641 Search VON+WILLEBRAND+DISEASE Search VON+WILLEBRAND+DISEASE
4 FACTOR VIII 979 65% 7% 935 Search FACTOR+VIII Search FACTOR+VIII
5 HEMOPHILIA A 628 75% 3% 454 Search HEMOPHILIA+A Search HEMOPHILIA+A
6 HEMOPHILIA 466 52% 5% 630 Search HEMOPHILIA Search HEMOPHILIA
7 HAEMOPHILIA B 378 87% 1% 188 Search HAEMOPHILIA+B Search HAEMOPHILIA+B
8 VON WILLEBRAND FACTOR 330 35% 6% 769 Search VON+WILLEBRAND+FACTOR Search VON+WILLEBRAND+FACTOR
9 RFVIIA 327 82% 1% 191 Search RFVIIA Search RFVIIA
10 FACTOR VIII INHIBITORS 305 96% 1% 95 Search FACTOR+VIII+INHIBITORS Search FACTOR+VIII+INHIBITORS

Key Words Plus



Rank Web of Science journal category Relevance score
(tfidf)
Class's shr.
of term's tot.
occurrences
Shr. of publ.
in class containing
term
Num. of publ.
in class
1 HEMOPHILIA A 815 60% 7% 889
2 RECOMBINANT FACTOR VIII 762 85% 3% 407
3 FACTOR IX INHIBITORS 624 94% 2% 225
4 COAGULATION FACTOR VIII 522 78% 3% 348
5 PORCINE FACTOR VIII 509 87% 2% 253
6 FACTOR VIII INHIBITORS 503 82% 2% 297
7 FACTOR VIII 459 36% 8% 1036
8 RFVIIA 415 85% 2% 216
9 SEVERE HEMOPHILIA A 391 70% 2% 323
10 INHIBITOR DEVELOPMENT 369 81% 2% 222

Journals



Rank Web of Science journal category Relevance score
(tfidf)
Class's shr.
of term's tot.
occurrences
Shr. of publ.
in class containing
term
Num. of publ.
in class
1 HAEMOPHILIA 3122 76% 16% 2160
2 JOURNAL OF THROMBOSIS AND HAEMOSTASIS 53 12% 3% 421
3 BLOOD COAGULATION & FIBRINOLYSIS 45 12% 3% 356
4 HAMOSTASEOLOGIE 35 28% 1% 107
5 BLOOD TRANSFUSION 6 10% 0% 54

Reviews



Title Publ. year Cit. Active references % act. ref.
to same field
Update on the pathophysiology and classification of von Willebrand disease: a report of the Subcommittee on von Willebrand Factor 2006 354 99 96%
von Willebrand disease (VWD): evidence-based diagnosis and management guidelines, the National Heart, Lung, and Blood Institute (NHLBI) Expert Panel report (USA) 2008 232 332 80%
Optimal treatment strategies for hemophilia: achievements and limitations of current prophylactic regimens 2015 2 59 100%
F8 gene mutation type and inhibitor development in patients with severe hemophilia A: systematic review and meta-analysis 2012 62 59 93%
Biochemistry and genetics of von Willebrand factor 1998 670 133 73%
International recommendations on the diagnosis and treatment of patients with acquired hemophilia A 2009 113 76 93%
von Willebrand factor biosynthesis, secretion, and clearance: connecting the far ends 2015 2 95 82%
Systematic Review: Benefits and Harms of In-Hospital Use of Recombinant Factor VIIa for Off-Label Indications 2011 90 84 76%
Modern haemophilia care 2012 48 113 93%
The diagnosis and management of factor VIII and IX inhibitors: a guideline from the United Kingdom Haemophilia Centre Doctors Organisation 2006 150 96 99%

Address terms



Rank Address term Relevance score
(tfidf)
Class's shr.
of term's tot.
occurrences
Shr. of publ.
in class containing
term
Num. of
publ. in
class
1 VAN CREVELDKLIN 217 84% 0.9% 119
2 HAEMOPHILIA 206 55% 2.0% 261
3 MALMO THROMBOSIS HAEMOSTASIS 179 93% 0.5% 67
4 COAGULAT DISORDERS 123 60% 1.0% 135
5 REG REFERENCE INHERITED BLEEDING DISORDERS 72 91% 0.2% 30
6 HEMOPHILIA 72 46% 0.9% 117
7 HEMOPHILIA THROMBOSIS 64 55% 0.6% 81
8 UNITAT HEMOFILIA 57 95% 0.1% 19
9 HEMOPHILIA TREATMENT 55 70% 0.3% 45
10 PLASMA PROT 50 51% 0.5% 70

Related classes at same level (level 2)



Rank Relatedness score Related classes
1 0.0000014069 PROTEIN C//ACTIVATED PROTEIN C//TISSUE FACTOR
2 0.0000011574 THROMBOTIC THROMBOCYTOPENIC PURPURA//ADAMTS 13//HEMOLYTIC UREMIC SYNDROME
3 0.0000010159 WARFARIN//CYP2C9//VKORC1
4 0.0000008946 CLOPIDOGREL//PRASUGREL//ASPIRIN RESISTANCE
5 0.0000006699 DYSFIBRINOGENEMIA//AFIBRINOGENEMIA//DYSFIBRINOGEN
6 0.0000006671 RED CELL DISTRIBUTION WIDTH//MYCOPLASMA SUIS//HEMOPLASMA
7 0.0000005677 CARDIOPULMONARY BYPASS//APROTININ//PERFUSION-UK
8 0.0000004651 BLOOD DONATION//SE MICHIGAN REG//BLOOD DONORS
9 0.0000004556 TRANSFUSION//VOX SANGUINIS//BLOOD TRANSFUSION
10 0.0000004282 IMMUNE THROMBOCYTOPENIA//IDIOPATHIC THROMBOCYTOPENIC PURPURA//IMMUNE THROMBOCYTOPENIC PURPURA